Business Description
Evotec SE is a Hamburg-based drug research and development company founded in 1993, working across the United States, Europe, and other global markets. The company works to discover and develop treatments for a wide range of serious conditions, including cancer, diabetes, heart disease, kidney and liver disorders, and rare diseases, among others. Evotec partners with leading universities, hospitals, research centers, and major pharmaceutical companies worldwide to advance its pipeline of new medicines. It serves a broad client base that includes biotech and pharma firms, academic institutions, and investor groups.
